What are the constraints and opportunities for HIVST scale-up in Africa? Evidence from Kenya, Malawi and South Africa

Journal of the International AIDS Society
H van RooyenMiriam Taegtmeyer

Abstract

HIV self-testing (HIVST) has the potential to increase uptake of HIV testing among untested populations in sub-Saharan Africa and is on the brink of scale-up. However, it is unclear to what extent HIVST would be supported by stakeholders, what policy frameworks are in place and how variations between contexts might influence country-preparedness for scale-up. This qualitative study assessed the perceptions of HIVST among stakeholders in three sub-Saharan countries. Fifty-four key informant interviews were conducted in Kenya (n=16), Malawi (n=26) and South Africa (n=12) with government policy makers, academics, activists, donors, procurement specialists, laboratory practitioners and health providers. A thematic analysis was conducted in each country and a common coding framework allowed for inter-country analysis to identify common and divergent themes across contexts. Respondents welcomed the idea of an accurate, easy-to-use, rapid HIV self-test which could increase testing across all populations. High-risk groups, such as men, Men who have sex with men (MSM), couples and young people in particular, could be targeted through a range of health facility and community-based distribution points. HIVST is already endorsed in Kenya, ...Continue Reading

References

Sep 29, 2004·The Lancet Infectious Diseases·Freya SpielbergMarcia Weaver
Nov 18, 2010·South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde·Marlise RichterAndy Gray
Jul 20, 2011·The New England Journal of Medicine·Myron S CohenUNKNOWN HPTN 052 Study Team
Sep 22, 2012·Tropical Medicine & International Health : TM & IH·Catrina MugglinUNKNOWN IeDEA Southern Africa
Mar 15, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sue Napierala MavedzengeElizabeth L Corbett
Jun 29, 2013·AIDS·Julie E MyersBernard M Branson
Aug 9, 2013·BMC Public Health·Janne KrauseRobert Colebunders
Feb 4, 2014·PloS One·Suzanne MamanUNKNOWN NIMH Project Accept (HPTN 043) study team
Jun 25, 2014·AIDS and Behavior·Vincent WongCharlene Brown
Jun 30, 2014·AIDS and Behavior·Samuel KalibalaPatricia Oluoch
Jul 6, 2014·AIDS and Behavior·C JohnsonM Taegtmeyer
Jul 6, 2014·AIDS and Behavior·Annette N BrownDrew B Cameron

❮ Previous
Next ❯

Citations

Mar 26, 2019·Journal of the International AIDS Society·Victoria WatsonMiriam Taegtmeyer
Mar 26, 2019·Journal of the International AIDS Society·Russell J DacombeMiriam Taegtmeyer
Dec 2, 2017·AIDS·Yilu QinJoseph D Tucker
Mar 21, 2020·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Patrick OyaroJared M Baeten
Jul 27, 2017·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Elisabeth M SchafferHarsha Thirumurthy
Jul 31, 2018·AIDS Care·Charlene HarichundQuarraisha Abdool Karim
Sep 14, 2019·AIDS Research and Therapy·Rose KisaRhoda K Wanyenze
Oct 30, 2016·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Helena HuergaTom Ellman
Jan 11, 2020·BMC Public Health·Jesal GohilMiriam Taegtmeyer
Jul 13, 2017·AIDS and Behavior·Charlene Harichund, M Moshabela
Mar 9, 2021·Frontiers in Public Health·Akeen HamiltonDonaldson F Conserve
Nov 10, 2020·The Journal of the Association of Nurses in AIDS Care : JANAC·Ci ZhangDeborah Koniak-Griffin
Feb 20, 2020·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Didier K EkoueviSerge Paul Eholie

❮ Previous
Next ❯

Software Mentioned

HIVST
NVivo

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.